Free Trial
OTCMKTS:EXDI

Exactus (EXDI) Stock Price, News & Analysis

Exactus logo

About Exactus Stock (OTCMKTS:EXDI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
257,300 shs
Average Volume
83,144 shs
Market Capitalization
$38.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.

Receive EXDI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exactus and its competitors with MarketBeat's FREE daily newsletter.

EXDI Stock News Headlines

Ish Msci France Regulatory News
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Starbreeze AB B (STZEb)
Exactus, Inc. to Present at BIO CEO & Investor Conference
See More Headlines

EXDI Stock Analysis - Frequently Asked Questions

Exactus's stock reverse split before market open on Thursday, October 28th 2021. The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Exactus investors own include Fulcrum Therapeutics (FULC), Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), PlayAGS (AGS), Astronics (ATRO) and Aytu BioPharma (AYTU).

Company Calendar

Today
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medicinals & Botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:EXDI
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-9,460,000.00
Pretax Margin
-15,131.74%

Debt

Sales & Book Value

Annual Sales
$2.07 million
Price / Cash Flow
N/A
Book Value
($0.09) per share
Price / Book
N/A

Miscellaneous

Free Float
209,652,000
Market Cap
$38.94 million
Optionable
Not Optionable
Beta
4.21
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:EXDI) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners